PuSH - Publikationsserver des Helmholtz Zentrums München

50 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
NCD Risk Factors Collaboration (Döring, A. ; Gieger, C. ; Heier, M. ; Meisinger, C. ; Peters, A. ; Stieber, J. ; Stöckl, D. ; Thorand, B.): Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 398, 957-980 (2021)
2.
Neumann, A.U. ; Goekkaya, M.* ; Dorgham, K.* ; Traidl-Hoffmann, C. & Gorochov, G.*: Tocilizumab in COVID-19 therapy: Who benefits, and how? Lancet 398, 299-300 (2021)
4.
GBD 2019 Risk Factors Collaborators (Breitner, S.): Global burden of 87 risk factors in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1223-1249 (2020)
5.
NCD Risk Factors Collaboration (Meisinger, C. ; Müller-Nurasyid, M. ; Peters, A.): Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: A pooled analysis of 2181 population-based studies with 65 million participants. Lancet 396, 1511-1524 (2020)
6.
von Mutius, E. & Smits, H.H.*: Primary prevention of asthma: From risk and protective factors to targeted strategies for prevention. Lancet 396, 854-866 (2020)
7.
Brunner, F.J.* et al.: Application of non-HDL cholesterol for population-based cardiovascular risk stratification: Results from the Multinational Cardiovascular Risk Consortium. Lancet 394, 2173-2183 (2019)
8.
Matthews, D.R.* et al.: Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): A 5-year, multicentre, randomised, double-blind trial. Lancet 394, 1519-1529 (2019)
9.
Lorkowski, S.* ; Richter, M.* ; Linseisen, J. & Watzl, B.*: Associations of fats and carbohydrates with cardiovascular disease and mortality—PURE and simple? Lancet 391, 1678-1679 (2018)
10.
Stumvoll, M.* & Tschöp, M.H.: Twice the benefits with twincretins? Lancet 392, 2142-2144 (2018)
11.
Wood, A.M.* et al.: Risk thresholds for alcohol consumption: Combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 391, 1513-1523 (2018)
12.
EUMODIC Consortium (Döring, A. ; Meisinger, C. ; Müller-Nurasyid, M. ; Peters, A. ; Stieber, J. ; Stöckl, D.): Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet 389, 37-55 (2017)
13.
Ezzati, M.* et al.: Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 390, 2627-2642 (2017)
14.
NCD Risk Factors Collaboration et al.: Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 387, 1377-1396 (2016)
15.
NCD Risk Factors Collaboration (Müller-Nurasyid, M. ; Peters, A. ; Stöckl, D. ; Ezzati, M.*): Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387, 1513-1530 (2016)
16.
Miras, A.* et al.: Ovarian hyperstimulation from ectopic hypersecretion of follicle stimulating hormone. Lancet 385, 392 (2015)
17.
Swerdlow, D.I.* et al.: HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials. Lancet 385, 351-361 (2015)
18.
Dick, K.J.* et al.: DNA methylation and body-mass index: A genome-wide analysis. Lancet 383, 1990-1998 (2014)
19.
Wormser, D.* et al.: Metabolic mediators of body-mass index and cardiovascular risk. Lancet 383, 2042-2043 (2014)
20.
Beelen, R.* et al.: Effects of long-term exposure to air pollution on natural-cause mortality: An analysis of 22 European cohorts within the multicentre ESCAPE project. Lancet 383, 785-795 (2013)